151751-Najiba-Chargi

CHAPTER 11 Pre-treatment low skeletal muscle mass is associated with chemotherapy dose-limiting toxicity in head and neck cancer patients undergoing primary chemoradiotherapy with high dose cisplatin S.I. Bril, A. Al-Mamgani, N. Chargi, P. Remeijer, L.A. Devriese, J.P. de Boer, R. de Bree Submitted